Skip to content

Chlamydia pneumoniae IgM Control Serum BC1371M

$94.00

Summary

  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Chlamydia pneumoniae IgM Control Serum
  • Applications: ELISA
  • IgM control serum
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL
SKU: BC1371M Categories: , Tags: , ,
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Chlamydia pneumoniae reactive IgM

species reactivity

Chlamydia pneumoniae

applications

ELISA

assay type

Indirect & quantitative

available size

3 mL

Chlamydia pneumoniae IgM Control Serum BC1371M

kit
Research area
Infectious Disease
Storage
Store at 2-8°C.
Associated products
Chlamydia trachomatis EB + RB Antigen (BA1372VSER)
Chlamydia trachomatis MOMP Antigen (BA1372VSR2)
Chlamydia trachomatis IgA Control Serum (BC1372A)
Chlamydia trachomatis IgG Control Serum (BC1372G)
Chlamydia trachomatis IgM Control Serum (BC1372M)
Chlamydia trachomatis IgA ELISA Kit (ESR1372A)
Chlamydia trachomatis IgG ELISA Kit (ESR1372G)
Chlamydia trachomatis IgM ELISA Kit (ESR1372M)
Chlamydia IgA ELISA Kit (ESR137A)
target relevance
Organism
Chlamydia pneumoniae
Protein names
Chlamydia pneumoniae
Structure and strains
Chlamydia pneumoniae is a species of Chlamydia, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia. It was known as the Taiwan acute respiratory agent (TWAR) from the names of the two original isolates Taiwan (TW-183) and an acute respiratory isolate designated AR-39. Briefly, it was known as Chlamydophila pneumoniae, and that name is used as an alternate in some sources. In some cases, to avoid confusion, both names are given.
Detection and diagnosis
Diagnosis of a Chlamydia pneumoniae infection is usually based on serological analysis by detection of specific serum antibodies. In the past, the microimmunofluorescence (MIF) test has been used as a reference method. However, it is increasingly replaced by species-specific ELISA tests, which allow for better standardization and automation. Seroprevalence rates rise rapidly in preschool age and reaches >50% after adolescence. Later on in life, the prevalence of C. pneumoniae increases even further due to frequently reoccurring infections and due to its propensity to lead to chronic disease. Beyond 65 years of age, seroprevalence may reach 70-100%. Seroprevalence rates for IgA are barely lower (approximately 60-70%) than for IgG

Data

Publications

Publications

pmid title authors citation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC1371M protocol

Documents

#
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information.